GlassScriptPhysician profile
Praneetha Puskuri
NPI 1851581656
$1,994.07
in general payments reported to CMS, 2019-2025
17 companies · $31.44 in 2025
The $31.44 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $40.04 · 2021: $391 · 2022: $435 · 2023: $583 · 2024: $288 · 2025: $31.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $448.29 | 2019-2024 | Xarelto |
| Pfizer INC. | $329.76 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $213.09 | 2019-2022 | |
| Gilead Sciences, INC. | $209.75 | 2022-2023 | Veklury |
| Astrazeneca Pharmaceuticals LP | $165.28 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $127.89 | 2021-2024 | |
| Medtronic, INC. | $127.71 | 2021-2025 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Merck Sharp & Dohme LLC | $114.50 | 2019-2023 | Zerbaxa, Dificid, Recarbrio |
| Vapotherm INC | $42.88 | 2021-2024 | Vapotherm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.44 | 2023 | Jardiance |
| Si-Bone, INC. | $33.11 | 2023 | |
| Alexion Pharmaceuticals, INC. | $31.48 | 2021 | |
| Mylan Specialty L.P. | $30.66 | 2019-2020 | |
| Abbott Laboratories | $22.55 | 2021 | |
| Inari Medical, INC. | $21.50 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioxcel Therapeutics, INC. | $18.02 | 2023 | Igalmi |
| E.R. Squibb & Sons, L.L.C. | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praneetha Puskuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.